daratumumab,Thalidomide,Dexamethasone,bortezomib
janssen,takeda
['bet', 'mmsm', 'pethema', 'daratumumab']
circulating tumor cells is an important prognostic marker. use of mass spec is a sensitive, faster, cheaper way to detect (even low) tumor burden, and differentiate between therapy moab and #myeloma clonal cells. #ash22 #imfash22 #mmsm #myeloma 
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.